ANRO
ANRO
NYSE · Pharmaceuticals

Alto Neuroscience Inc

$28.26
-0.21 (-0.74%)
As of Aug 8, 1:54 AM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 16 89%
Hold 2 11%
Sell 0 0%
Price Target
Analyst Price Target -21.5% upside
Low Target $14.63
Average Target $22.17
High Target $27.87
Current Price $28.26
Current
$28.26
Target
$22.17
$14.63 $22.17 avg $27.87
Scenario Analysis
Bear Case
$14.63
-48.2%
Low target
Base Case
$22.17
-21.5%
Avg target
Bull Case
$27.87
+-1.4%
High target
Risk/Reward
0.0x
Unfavorable
Price in Context
52-Week High
$29.49
-4.2% from high
52-Week Low
$3.00
+842.0% from low
Target vs 52W High
$22.17
-24.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%